BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2242792)

  • 1. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis.
    Wüthrich B; Joller-Jemelka H; Helfenstein U; Grob PJ
    Dermatologica; 1990; 181(2):92-7. PubMed ID: 2242792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
    Kägi MK; Joller-Jemelka H; Wüthrich B
    Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of immunological markers in patients with "intrinsic" type atopic dermatitis].
    Yamashiro M; Okubo Y; Kato Y; Tamaki T; Koga M
    Arerugi; 2002 Jul; 51(7):552-8. PubMed ID: 12201168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
    Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
    Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of serologic immune parameters in inflammatory skin diseases.
    Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
    Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous CD30+ cells in children with atopic dermatitis.
    Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
    Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.
    Hanafusa T; Matsui S; Murota H; Tani M; Igawa K; Katayama I
    Clin Exp Immunol; 2013 Jun; 172(3):507-12. PubMed ID: 23600840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients.
    Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH
    J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
    Wüthrich B; Kägi MK; Joller-Jemelka H
    Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood.
    Halmerbauer G; Frischer T; Koller DY
    Allergy; 1997 Jul; 52(7):765-9. PubMed ID: 9265994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
    Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
    J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
    Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
    Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
    Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.
    Suzuki H; Sugaya M; Nakajima R; Oka T; Takahashi N; Nakao M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Dec; 45(12):1440-1443. PubMed ID: 30289574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble interleukin-2 receptor in eosinophilia.
    Kaito K; Otsubo H; Ogasawara Y; Kimura H; Kurihara E; Koike M; Aiso M; Kobayashi M
    Acta Haematol; 2003; 109(1):23-8. PubMed ID: 12486319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
    Czech W; Krutmann J; Schöpf E; Kapp A
    Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis.
    Uchio E; Ono S; Ikezawa Z; Ohno S
    Allergy; 1999 Feb; 54(2):135-41. PubMed ID: 10221436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
    Szeimies RM; Rueff F; Kaudewitz P
    Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
    Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine levels in atopic dermatitis.
    Yoshizawa Y; Nomaguchi H; Izaki S; Kitamura K
    Clin Exp Dermatol; 2002 May; 27(3):225-9. PubMed ID: 12072014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.